Product Information

HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.1435 per EA under NDC 10702019110. Its NADAC has been published 315 times since Nov 11, 2020.

FDA first approved this application on Jun 21, 2017. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1435per EA
DEA Schedule CII

Strength

325; 10 mg/1; mg/1

Manufacturer

KVK-Tech Inc.

NDC

10702019110

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209037

FDA Approved

6/21/2017

TE Code

AA

On Market Since

6/22/2017

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET has been published 315 times since Nov 11, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1435 per EA
All-time high$0.1684 (Jul 10, 2024)
All-time low$0.1170 (Dec 22, 2021)
52-week high$0.1607
52-week low$0.1435
Median price$0.1384
Average price$0.1425
Largest weekly change+17.4% (Jun 19, 2024)
Weeks tracked315
Tracking sinceNov 11, 2020

Price History

1W

-3.3%

1M

-5.8%

3M

-5.7%

6M

-6.5%

1Y

-10.0%

3Y

+6.2%

5Y

+21.5%

All

-0.1%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET, manufactured by KVK-Tech Inc., is $0.1435 per EA (NDC 10702019110), effective Nov 18, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET has held within roughly two percent of its current level. It has been tracked across 315 weekly CMS publications since Nov 11, 2020.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?

Since Nov 11, 2020, the NADAC for HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET has ranged from a low of $0.1170 (Dec 22, 2021) to a high of $0.1684 (Jul 10, 2024), with a median of $0.1384 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET, is $0.1347 per EA — about 6% below HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET (NDC 10702019110) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.